Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-093901
Filing Date
2022-04-01
Accepted
2022-04-01 17:29:59
Documents
57
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q d311408d10q.htm   iXBRL 10-Q 1221025
2 EX-31.1 d311408dex311.htm EX-31.1 10573
3 EX-31.2 d311408dex312.htm EX-31.2 10653
4 EX-32 d311408dex32.htm EX-32 5326
  Complete submission text file 0001193125-22-093901.txt   5486695

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20220228.xsd EX-101.SCH 31432
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20220228_cal.xml EX-101.CAL 33977
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20220228_def.xml EX-101.DEF 264572
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220228_lab.xml EX-101.LAB 327520
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220228_pre.xml EX-101.PRE 298710
51 EXTRACTED XBRL INSTANCE DOCUMENT d311408d10q_htm.xml XML 913238
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 22799531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances